Pure Global AI
NCT05843006Completed

Sweat Analysis as Prognosticator After Heart Attack

SWEAT Analysis for Predicting Patient Outcome After HEART Attack
Region Örebro CountyClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Acute Myocardial Infarction
Drug/Device/Intervention
Examination and analysis of sweat and blood samples at baseline and at follow up
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Region Örebro County
Location
Örebro, Sweden
Timeline & enrollment
Phase
N/A
Start date
Mar 21, 2022
End date
Mar 31, 2023
Enrollment
24 participants
Primary outcome

Inflammation panels in sweat and blood correlated to clinical outcome

Summary

This study characterizes non-invasive body inflammation response in sweat and blood of
 patients suffering from acute myocardial infarction and explores the potential of
 non-invasive sweat analysis a an innovative approach for predicting patient outcome.

ICD-10 classifications
Acute myocardial infarctionAcute myocardial infarction, unspecifiedAcute subendocardial myocardial infarctionCertain current complications following acute myocardial infarctionOther current complications following acute myocardial infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05843006
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05843006 through Pure Global AI's free database. This phase not specified trial is sponsored by Region Örebro County and is currently Completed. The study focuses on Acute Myocardial Infarction. Target enrollment is 24 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.